Cargando…
Fabrication of An Immunostimulatory Supramolecular Nanomedicine for Potent Cancer Chemoimmunotherapy
[Image: see text] Chemoimmunotherapy can boost strong antitumor immune responses by triggering immunogenic cell death (ICD), which highlights a promising prospect in clinical applications. However, current chemoimmunotherapy shows limited efficacy due to the low delivery efficiency and insufficient...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685430/ https://www.ncbi.nlm.nih.gov/pubmed/38034980 http://dx.doi.org/10.1021/jacsau.3c00515 |
_version_ | 1785151628922322944 |
---|---|
author | Yu, Xinyang Qi, Shaolong Cao, Fangfang Yang, Kai Li, Hongjian Peng, Kun Liu, Zhida Bai, Bing Buljan, Marija Chen, Xiaoyuan Yu, Guocan |
author_facet | Yu, Xinyang Qi, Shaolong Cao, Fangfang Yang, Kai Li, Hongjian Peng, Kun Liu, Zhida Bai, Bing Buljan, Marija Chen, Xiaoyuan Yu, Guocan |
author_sort | Yu, Xinyang |
collection | PubMed |
description | [Image: see text] Chemoimmunotherapy can boost strong antitumor immune responses by triggering immunogenic cell death (ICD), which highlights a promising prospect in clinical applications. However, current chemoimmunotherapy shows limited efficacy due to the low delivery efficiency and insufficient immunogenicity of available chemotherapeutic drugs. A supramolecular polymeric nanomedicine (Pt-Tu@NP) is herein reported using cucurbit[7]uril-based host–guest recognition and noncovalent self-assembly. Pt-Tu@NPs have excellent biodistribution and strongly evoke the endoplasmic reticulum stress-mediated ICD of tumor cells, triggering potent antitumor immune responses by promoting dendritic cell (DC) maturation and cytotoxic T cell infiltration. The coordinated butyrate promotes a positive feedback regulation between DCs and CD8(+) T cells. Pt-Tu@NPs stimulate immune cold tumors into hot ones, working in synergy with an immune checkpoint blockade to effectively suppress tumor growth and metastasis, which suggests a promising approach for cancer chemoimmunotherapy. |
format | Online Article Text |
id | pubmed-10685430 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-106854302023-11-30 Fabrication of An Immunostimulatory Supramolecular Nanomedicine for Potent Cancer Chemoimmunotherapy Yu, Xinyang Qi, Shaolong Cao, Fangfang Yang, Kai Li, Hongjian Peng, Kun Liu, Zhida Bai, Bing Buljan, Marija Chen, Xiaoyuan Yu, Guocan JACS Au [Image: see text] Chemoimmunotherapy can boost strong antitumor immune responses by triggering immunogenic cell death (ICD), which highlights a promising prospect in clinical applications. However, current chemoimmunotherapy shows limited efficacy due to the low delivery efficiency and insufficient immunogenicity of available chemotherapeutic drugs. A supramolecular polymeric nanomedicine (Pt-Tu@NP) is herein reported using cucurbit[7]uril-based host–guest recognition and noncovalent self-assembly. Pt-Tu@NPs have excellent biodistribution and strongly evoke the endoplasmic reticulum stress-mediated ICD of tumor cells, triggering potent antitumor immune responses by promoting dendritic cell (DC) maturation and cytotoxic T cell infiltration. The coordinated butyrate promotes a positive feedback regulation between DCs and CD8(+) T cells. Pt-Tu@NPs stimulate immune cold tumors into hot ones, working in synergy with an immune checkpoint blockade to effectively suppress tumor growth and metastasis, which suggests a promising approach for cancer chemoimmunotherapy. American Chemical Society 2023-11-07 /pmc/articles/PMC10685430/ /pubmed/38034980 http://dx.doi.org/10.1021/jacsau.3c00515 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Yu, Xinyang Qi, Shaolong Cao, Fangfang Yang, Kai Li, Hongjian Peng, Kun Liu, Zhida Bai, Bing Buljan, Marija Chen, Xiaoyuan Yu, Guocan Fabrication of An Immunostimulatory Supramolecular Nanomedicine for Potent Cancer Chemoimmunotherapy |
title | Fabrication of An
Immunostimulatory Supramolecular
Nanomedicine for Potent Cancer Chemoimmunotherapy |
title_full | Fabrication of An
Immunostimulatory Supramolecular
Nanomedicine for Potent Cancer Chemoimmunotherapy |
title_fullStr | Fabrication of An
Immunostimulatory Supramolecular
Nanomedicine for Potent Cancer Chemoimmunotherapy |
title_full_unstemmed | Fabrication of An
Immunostimulatory Supramolecular
Nanomedicine for Potent Cancer Chemoimmunotherapy |
title_short | Fabrication of An
Immunostimulatory Supramolecular
Nanomedicine for Potent Cancer Chemoimmunotherapy |
title_sort | fabrication of an
immunostimulatory supramolecular
nanomedicine for potent cancer chemoimmunotherapy |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685430/ https://www.ncbi.nlm.nih.gov/pubmed/38034980 http://dx.doi.org/10.1021/jacsau.3c00515 |
work_keys_str_mv | AT yuxinyang fabricationofanimmunostimulatorysupramolecularnanomedicineforpotentcancerchemoimmunotherapy AT qishaolong fabricationofanimmunostimulatorysupramolecularnanomedicineforpotentcancerchemoimmunotherapy AT caofangfang fabricationofanimmunostimulatorysupramolecularnanomedicineforpotentcancerchemoimmunotherapy AT yangkai fabricationofanimmunostimulatorysupramolecularnanomedicineforpotentcancerchemoimmunotherapy AT lihongjian fabricationofanimmunostimulatorysupramolecularnanomedicineforpotentcancerchemoimmunotherapy AT pengkun fabricationofanimmunostimulatorysupramolecularnanomedicineforpotentcancerchemoimmunotherapy AT liuzhida fabricationofanimmunostimulatorysupramolecularnanomedicineforpotentcancerchemoimmunotherapy AT baibing fabricationofanimmunostimulatorysupramolecularnanomedicineforpotentcancerchemoimmunotherapy AT buljanmarija fabricationofanimmunostimulatorysupramolecularnanomedicineforpotentcancerchemoimmunotherapy AT chenxiaoyuan fabricationofanimmunostimulatorysupramolecularnanomedicineforpotentcancerchemoimmunotherapy AT yuguocan fabricationofanimmunostimulatorysupramolecularnanomedicineforpotentcancerchemoimmunotherapy |